Soltis Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,164	Closed	-$258K	–	384
2024 Q3	$258K	Buy	+2,164	New	+$258K	0.03%	300
2024 Q2	–	Sell	-1,618	Closed	-$208K	–	341
2024 Q1	$208K	Buy	+1,618	New	+$208K	0.02%	284